Therapeutic targets in chagas disease
Loading...
Date
Advisor
Coadvisor
Graduate program
Undergraduate course
Journal Title
Journal ISSN
Volume Title
Publisher
Type
Book chapter
Access right
Acesso restrito
Abstract
Optimal pharmacotherapy occurs when we have selectivity and no toxicity. The discovery of specific pathways or enzymes that are vital forcell or parasite survival is also vital for the design of new specific, non-toxic drugs for the treatment of cancer, microbial or parasitic diseases. This chapter describes the main validated therapeutic targets in the research of new drugs for the treatment of Chagas' disease, such as cysteine proteases, ergosterol metabolic pathways, thiol-dependent mechanisms (trypanothione reductase), glycolytic pathways, transsialidase enzymes, the transport and metabolism of polyamines, among others, as well as examples from the scientific literature. This also includes what is already in clinical trials that involves the specified targets.
Description
Keywords
Chagas' disease, Molecular targets, T. cruzi, Therapeutic targets
Language
English
Citation
Chagas Disease: Prevalence, Diagnosis and Treatment Options, p. 85-116.
Related itens
Sponsors
Other forms of access
